The U.S. charged four people in connection with an alleged scheme, which now involves 193 defendants, to defraud federal health care programs of more than US$2.75 billion through the submission of fake opioid prescriptions.
The U.S. charged four people in connection with an alleged scheme, which now involves 193 defendants, to defraud federal health care programs of more than US$2.75 billion through the submission of fake opioid prescriptions.